Bleeding diathesis in patients with mast cell activation disease

Holger Seidel; Gerhard J. Molderings; Johannes Oldenburg; Kirsten Meis; Ulrich W. Kolck; Jürgen Homann; Hans-Jörg Hertfelder

doi:10.1160/TH11-05-0351

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2011; 106(05): 987-989
DOI: 10.1160/TH11-05-0351

Letters to the Editor

Schattauer GmbH

Bleeding diathesis in patients with mast cell activation disease

Holger Seidel^*

¹Institute of Experimental Haematology and Transfusion Medicine, University Clinic Bonn, Bonn, Germany

²Current address: Institute of Hemostasis and Transfusion Medicine, University Clinic Düsseldorf, Düsseldorf, Germany

,

Gerhard J. Molderings^*

³Institute of Human Genetics, University Hospital of Bonn, Bonn, Germany

,

Johannes Oldenburg

¹Institute of Experimental Haematology and Transfusion Medicine, University Clinic Bonn, Bonn, Germany

,

Kirsten Meis

⁴Evangelische Kliniken Bonn, Waldkrankenhaus, Bonn, Germany

,

Ulrich W. Kolck

⁴Evangelische Kliniken Bonn, Waldkrankenhaus, Bonn, Germany

,

Jürgen Homann

⁴Evangelische Kliniken Bonn, Waldkrankenhaus, Bonn, Germany

⁵Current address: Gemeinschaftskrankenhaus Bonn, Bonn, Germany

,

Hans-Jörg Hertfelder^*

¹Institute of Experimental Haematology and Transfusion Medicine, University Clinic Bonn, Bonn, Germany

› Author Affiliations

Abstract

PDF Download

PDF (117 kb)

References

References
1 Campbell Jr, EW, Hector D, Gossain V. Heparin activity in systemic mastocytosis. Ann Intern Med 1979; 90: 940-941.
2 Adler SN, Klein RA, Lyon DT. Bleeding after liver biopsy in a patient with systemic mastocytosis and malabsorption. J Clin Gastroenterol 1985; 7: 350-353.
3 Horan RF, Austen KF. Systemic mastocytosis: restrospective review of a decade´s clinical experience at the Brigham and Women´s Hospital. J Invest Dermatol 1991; 96 (Suppl.) 5S-14S.
4 Parker RI. Hematologic aspects of systemic mastocytosis. Mast Cell Disorders 2000; 14: 557-568.
5 Puretic S, Milavec D. Clinical varieties of mastocytoses. Acta Med Croatica 2001; 55: 61-66.
6 Koenig M, Morel J, Reynaud J. et al. An unusual cause of spontaneous bleeding in the intensive care unit - mastocytosis: a case report. Cases J 2008; 1: 100
7 Sucker C, Mansmann G, Steiner S. et al. Fatal bleeding due to a heparin-like anticoagulant in a 37-year-old woman suffering from systemic mastocytosis. Clin Appl Thromb Hemost 2008; 14: 360-364.
8 Steiner DR, Gonzalez NC, Wood JG. Mast cells mediate the microvascular inflammatory response to systemic hypoxia. J Appl Physiol 2003; 94: 325-334.
9 Stevens RL, Fox CC, Lichtenstein LM. et al. Identification of chondroitin sulfate E proteoglycans and heparin proteoglycans in the secretory granules of human lung mast cells. Proc Natl Acad Sci USA 1988; 85: 2284-2287.
10 Sillaber C, Baghestanian M, Bevec D. et al. The mast cell as site of tissue type plasminogen activator production and fibrinolysis. J Immunol 1999; 62: 1032-1041.
11 Strbian D, Karjalainen-Lindsberg ML, Kovanen PT. et al. Mast cell stabilization reduces hemorrhage formation and mortality after administration of thrombolytics in experimental ischemic stroke. Circulation 2007; 116: 411-418.
12 Hertfelder HJ, Popov-Cenic S. Short-time centrifugation at high centrifugal forces in plasma preparation for tPA activity determination. Thromb Res 1990; 59: 417-420.
13 Molderings GJ, Meis K, Kolck UW. et al. Comparative analysis of mutation of tyrosine kinase kit in mast cells from patients with systemic mast cell activation syndrome and healthy subjects. Immunogenetics 2010; 62: 721-727.

Supplementary Material

Online Supplementary Material (PDF)